Markets
P/E = market value ÷ net profit of the last 12 months (profitable companies only). P/B = market value ÷ book value (positive equity only). Latest close. Lower multiples aren't a sign a stock is cheap or a buy.
Stocks ranked
8
Median P/E
83.3×
Median P/B
2.5×
| # | Stock | Price | Day | Market value | P/E | P/B |
|---|---|---|---|---|---|---|
| 1 | Celltrion068270 · KOSPI · Biotech & Pharma | ₩191,600 | +1.22% | 28.2× | 2.5× | |
| 2 | Samsung Biologics207940 · KOSPI · Biotech & Pharma | ₩1,487,000 | +8.86% | 34.7× | 8.2× | |
| 3 | Celltrion Pharm068760 · KOSDAQ · Biotech & Pharma | ₩36,650 | −0.41% | 39.3× | 3.6× | |
| 4 | Alteogen196170 · KOSDAQ · Biotech & Pharma | ₩211,500 | −3.86% | 76.3× | 27.5× | |
| 5 | Samsung Epis Holdings0126Z0 · KOSPI · Holding companies | ₩309,500 | +0.81% | 90.3× | 1.3× | |
| 6 | IMBiologics493280 · KOSDAQ · Biotech & Pharma | ₩13,160 | −4.64% | 222.8× | 1.5× | |
| 7 | SAM Chun Dang Pharm000250 · KOSDAQ · Biotech & Pharma | ₩182,700 | −3.13% | 241.0× | 14.2× | |
| 8 | Prestige BioPharma950210 · KOSPI · Biotech & Pharma | ₩4,020 | −3.25% | 15194.8× | 797.3× |
5 loss-making or unreported companies have no P/E.
End-of-day data · Oct 30, 2026
Source: KRX statistical information